India's Pharmaceutical Exports

Country Profile

Sierra Leone

Sierra Leone is a growing market for Indian pharmaceuticals — $109M in FY 2025–26, with 9.4× growth over the past decade. Medicines accounts for 97% of shipments, with vaccines contributing $1.42M. The compound annual growth rate since FY2015 stands at 22.5%.

🇸🇱 $109M · 9.4× growth since FY2015 · 22.5% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$109M
Exports FY2025–26 DGCIS
9.4×
Growth FY2015→2026
22.5%
CAGR FY2015→2026
97%
Medicines Share
5
Product Categories Supplied
Sierra Leone is a growing market for Indian pharmaceuticals — $109M in FY 2025–26, with 9.4× growth over the past decade. Medicines accounts for 97% of shipments, with vaccines contributing $1.42M. The compound annual growth rate since FY2015 stands at 22.5%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $106M (97.4%) Vaccines $1.42M (1.3%) Surgical & Hospital Supplies $643K (0.6%) Medicine Ingredients $552K (0.5%) Traditional & Herbal $200K (0.2%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Sierra Leone in the RBI overseas direct investment dataset (2011–2026).